Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis

Does it confound outcomes assessment?

Luke Rudmik, Jess MacE, Berrylin J. Ferguson, Timothy Smith

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Objectives/Hypothesis: To determine if chronic rhinosinusitis (CRS)-specific health-related quality-of-life (HRQoL) outcomes are affected by concurrent septoplasty performed during endoscopic sinus surgery (ESS) for medically refractory CRS. Study Design: Prospective, multicenter cohort study. Methods: A total of 221 patients with medically refractory CRS without nasal polyposis who elected primary ESS were included in this study. Patients were dichotomized into two cohorts: concurrent septoplasty (n = 108) or no septoplasty (n = 113) during ESS. The main outcomes of interest included two CRS-specific HRQoL instruments: the Rhinosinusitis Disability Index (RSDI) and the Chronic Sinusitis Survey (CSS). Symptom presentation was assessed using eight sinonasal visual analog scale (VAS) symptom scores. Results: There were no differences in CRS-specific HRQoL improvements on all RSDI and CSS measures following ESS between cohorts with or without septoplasty (all P >.05). In patients with medically refractory CRS, the presence of septal deviation did not result in a different CRS-specific symptom presentation compared to patients without septal deviation (all baseline VAS symptom score comparisons P >.295). Conclusions: To optimize nasal patency and improve surgical access, septoplasty is commonly performed during ESS. Based on the results of this study, concurrent septoplasty does not appear to affect CRS-specific HRQoL or symptom outcomes and does not function as a confounding factor in HRQoL improvement.

Original languageEnglish (US)
Pages (from-to)2679-2683
Number of pages5
JournalLaryngoscope
Volume121
Issue number12
DOIs
StatePublished - Dec 2011

Fingerprint

Quality of Life
Outcome Assessment (Health Care)
Sinusitis
Quality Improvement
Visual Analog Scale
Nose
Cohort Studies
Multicenter Studies
Prospective Studies
Surveys and Questionnaires

Keywords

  • chronic rhinosinusitis
  • endoscopic
  • quality of life
  • Septoplasty
  • sinusitis
  • surgery

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis : Does it confound outcomes assessment? / Rudmik, Luke; MacE, Jess; Ferguson, Berrylin J.; Smith, Timothy.

In: Laryngoscope, Vol. 121, No. 12, 12.2011, p. 2679-2683.

Research output: Contribution to journalArticle

Rudmik, Luke ; MacE, Jess ; Ferguson, Berrylin J. ; Smith, Timothy. / Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis : Does it confound outcomes assessment?. In: Laryngoscope. 2011 ; Vol. 121, No. 12. pp. 2679-2683.
@article{1e21227598b744228e6bc31f400baca5,
title = "Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis: Does it confound outcomes assessment?",
abstract = "Objectives/Hypothesis: To determine if chronic rhinosinusitis (CRS)-specific health-related quality-of-life (HRQoL) outcomes are affected by concurrent septoplasty performed during endoscopic sinus surgery (ESS) for medically refractory CRS. Study Design: Prospective, multicenter cohort study. Methods: A total of 221 patients with medically refractory CRS without nasal polyposis who elected primary ESS were included in this study. Patients were dichotomized into two cohorts: concurrent septoplasty (n = 108) or no septoplasty (n = 113) during ESS. The main outcomes of interest included two CRS-specific HRQoL instruments: the Rhinosinusitis Disability Index (RSDI) and the Chronic Sinusitis Survey (CSS). Symptom presentation was assessed using eight sinonasal visual analog scale (VAS) symptom scores. Results: There were no differences in CRS-specific HRQoL improvements on all RSDI and CSS measures following ESS between cohorts with or without septoplasty (all P >.05). In patients with medically refractory CRS, the presence of septal deviation did not result in a different CRS-specific symptom presentation compared to patients without septal deviation (all baseline VAS symptom score comparisons P >.295). Conclusions: To optimize nasal patency and improve surgical access, septoplasty is commonly performed during ESS. Based on the results of this study, concurrent septoplasty does not appear to affect CRS-specific HRQoL or symptom outcomes and does not function as a confounding factor in HRQoL improvement.",
keywords = "chronic rhinosinusitis, endoscopic, quality of life, Septoplasty, sinusitis, surgery",
author = "Luke Rudmik and Jess MacE and Ferguson, {Berrylin J.} and Timothy Smith",
year = "2011",
month = "12",
doi = "10.1002/lary.22361",
language = "English (US)",
volume = "121",
pages = "2679--2683",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Concurrent septoplasty during endoscopic sinus surgery for chronic rhinosinusitis

T2 - Does it confound outcomes assessment?

AU - Rudmik, Luke

AU - MacE, Jess

AU - Ferguson, Berrylin J.

AU - Smith, Timothy

PY - 2011/12

Y1 - 2011/12

N2 - Objectives/Hypothesis: To determine if chronic rhinosinusitis (CRS)-specific health-related quality-of-life (HRQoL) outcomes are affected by concurrent septoplasty performed during endoscopic sinus surgery (ESS) for medically refractory CRS. Study Design: Prospective, multicenter cohort study. Methods: A total of 221 patients with medically refractory CRS without nasal polyposis who elected primary ESS were included in this study. Patients were dichotomized into two cohorts: concurrent septoplasty (n = 108) or no septoplasty (n = 113) during ESS. The main outcomes of interest included two CRS-specific HRQoL instruments: the Rhinosinusitis Disability Index (RSDI) and the Chronic Sinusitis Survey (CSS). Symptom presentation was assessed using eight sinonasal visual analog scale (VAS) symptom scores. Results: There were no differences in CRS-specific HRQoL improvements on all RSDI and CSS measures following ESS between cohorts with or without septoplasty (all P >.05). In patients with medically refractory CRS, the presence of septal deviation did not result in a different CRS-specific symptom presentation compared to patients without septal deviation (all baseline VAS symptom score comparisons P >.295). Conclusions: To optimize nasal patency and improve surgical access, septoplasty is commonly performed during ESS. Based on the results of this study, concurrent septoplasty does not appear to affect CRS-specific HRQoL or symptom outcomes and does not function as a confounding factor in HRQoL improvement.

AB - Objectives/Hypothesis: To determine if chronic rhinosinusitis (CRS)-specific health-related quality-of-life (HRQoL) outcomes are affected by concurrent septoplasty performed during endoscopic sinus surgery (ESS) for medically refractory CRS. Study Design: Prospective, multicenter cohort study. Methods: A total of 221 patients with medically refractory CRS without nasal polyposis who elected primary ESS were included in this study. Patients were dichotomized into two cohorts: concurrent septoplasty (n = 108) or no septoplasty (n = 113) during ESS. The main outcomes of interest included two CRS-specific HRQoL instruments: the Rhinosinusitis Disability Index (RSDI) and the Chronic Sinusitis Survey (CSS). Symptom presentation was assessed using eight sinonasal visual analog scale (VAS) symptom scores. Results: There were no differences in CRS-specific HRQoL improvements on all RSDI and CSS measures following ESS between cohorts with or without septoplasty (all P >.05). In patients with medically refractory CRS, the presence of septal deviation did not result in a different CRS-specific symptom presentation compared to patients without septal deviation (all baseline VAS symptom score comparisons P >.295). Conclusions: To optimize nasal patency and improve surgical access, septoplasty is commonly performed during ESS. Based on the results of this study, concurrent septoplasty does not appear to affect CRS-specific HRQoL or symptom outcomes and does not function as a confounding factor in HRQoL improvement.

KW - chronic rhinosinusitis

KW - endoscopic

KW - quality of life

KW - Septoplasty

KW - sinusitis

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=82155162380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82155162380&partnerID=8YFLogxK

U2 - 10.1002/lary.22361

DO - 10.1002/lary.22361

M3 - Article

VL - 121

SP - 2679

EP - 2683

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 12

ER -